358 related articles for article (PubMed ID: 24393810)
21. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of monoamine oxidase by phthalide analogues.
Strydom B; Bergh JJ; Petzer JP
Bioorg Med Chem Lett; 2013 Mar; 23(5):1269-73. PubMed ID: 23374869
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues.
Mostert S; Mentz W; Petzer A; Bergh JJ; Petzer JP
Bioorg Med Chem; 2012 Dec; 20(24):7040-50. PubMed ID: 23122934
[TBL] [Abstract][Full Text] [Related]
24. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
Manley-King CI; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
[TBL] [Abstract][Full Text] [Related]
26. 2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors.
Takao K; Endo S; Nagai J; Kamauchi H; Takemura Y; Uesawa Y; Sugita Y
Bioorg Chem; 2019 Nov; 92():103285. PubMed ID: 31561103
[TBL] [Abstract][Full Text] [Related]
27. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
Hassan SY; Khattab SN; Bekhit AA; Amer A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
[TBL] [Abstract][Full Text] [Related]
30. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors.
Takao K; Takemura Y; Nagai J; Kamauchi H; Hoshi K; Mabashi R; Uesawa Y; Sugita Y
Bioorg Med Chem; 2021 Jul; 42():116255. PubMed ID: 34119696
[TBL] [Abstract][Full Text] [Related]
32. Indanones as high-potency reversible inhibitors of monoamine oxidase.
Mostert S; Petzer A; Petzer JP
ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
[TBL] [Abstract][Full Text] [Related]
33. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
Strydom B; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
[TBL] [Abstract][Full Text] [Related]
34. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.
Reniers J; Meinguet C; Moineaux L; Masereel B; Vincent SP; Frederick R; Wouters J
Eur J Med Chem; 2011 Dec; 46(12):6104-11. PubMed ID: 22018876
[TBL] [Abstract][Full Text] [Related]
36. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
37. Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Nov; 22(21):6632-5. PubMed ID: 23010267
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
39. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
[TBL] [Abstract][Full Text] [Related]
40. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
Engelbrecht I; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]